26 Apr, 2023 New Results for RNAi Mediated Lowering of HTT Presented at 2023 CHDI Conference
Posted at 12:29h
in Capella
We presented new results on our C16-siRNA conjugate approach to lowering Huntingtin in the CNS at the CHDI Foundation’s 18th Annual Huntington’s Disease Therapeutics Conference, taking place April 24-27, 2023 in Dubrovnik, Croatia.
Cantley, et al. – A New Approach to HTT-Lowering Using C16-siRNA Conjugates
